Language Selection

English French German Italian Portuguese Spanish

Premarket Movers: Novell Down After Deal

Filed under
Misc

Microsoft Corp.'s support agreement with Novell Inc. dominated the early session, with investors trying to sort out the winners and losers of the industry-shaking deal.

Shareholders initially punished Novell, sending its stock down ahead of the bell even after Microsoft, in essence, gave its stamp of approval to Novell's version of the open-source operating software Linux over competitor Red Hat Inc.'s.

"Microsoft is signaling a preference to prop up the market laggard in the Linux market to the detriment of Red Hat," said Sun Trust analyst Terry Tillman.

But the analyst doesn't expect Novell to benefit necessarily. "Importantly, we believe this partnership does nothing to stem Novell's NetWare declines nor Microsoft's focus on impairing Novell's growth prospects," Tillman wrote.

Novell shares lost as much as 23 cents, or 3.4 percent to $6.56 in premarket electronic trading before shares recovered, matching their Thursday close at $6.79 on the Nasdaq. In the past year, the stock has ranged from $5.73 to $9.83.

Microsoft shares rose 6 cents to $28.83. The company will be able to offer support for both its proprietary Windows operating system and Novell's Linux system as part of the deal, which could expand its corporate customer base. The software company's shares closed Thursday at $28.77 on the Nasdaq.

Meanwhile, Red Hat, which provides a different version of Linux than Novell, saw its shares drop on the news. Baird analyst Steven Ashley downgraded the stock to "Neutral," from "Outperform," saying there is "simply too much near-term noise and uncertainty" in the open-source market.

Red Hat lost as much as 50 cents, or 3 percent, before regaining some ground. Shares were lately down 21 cents, to $15.89 in off-hours trading. The stock closed Thursday at $16.10 on the Nasdaq, where it has ranged from $13.70 to $32.48 in the past year.

Leaving software for pharmaceuticals, Inspire Pharma Inc. shot up ahead of the bell after reporting that its drug to treat cystic fibrosis was "well tolerated" in a Phase II clinical trial.

"There were no serious adverse events or patient withdrawals during the trial," the company said in a statement. The next step is to enroll patients in a Phase III trial to test effectiveness.

Cystic fibrosis is a hereditary lung and digestive system disease that affects about 30,000 children in the United States, according to the Cystic Fibrosis Foundation.

Inspire shares added 42 cents, or 7.9 percent, to $5.71 in the early session after closing Thursday at $5.29 on the Nasdaq. In the past year, Inspire has ranged from $3.92 to $7.88.

Shares in Encysive Pharmaceuticals Inc. rose before the bell after the drug maker said it responded to regulators who requested more information about the company's Thelin hypertension drug.

The Food and Drug Administration said it needed the information before it could make a decision on whether to approve Thelin.

Investors, who had punished Encysive in July when the FDA requested the information, cheered the move, sending the stock up 77 cents, or 15 percent, to $5.90 in electronic premarket trading. The shares closed Thursday at $5.13 on the Nasdaq, where they have ranged from $3.29 to $11.64 in the past year.

Associated Press

More in Tux Machines

Linux or GNU/Linux – Here is What Every User Should Know.

The parties who work for the project deserves credit though the task is important thing than who did it. But people fear naming it just Linux won’t give a community spirit to the distributions rather it would make it just a business perspective. The project to develop complete free version of OS was started by GNU project years before the the work of Linux initiated. The core component of the system is GNU and Free Software Foundation(FSF)’s founder Richard Stallman called it as GNU/Linux whereas the name came into rise after Yggdrasil Linux distribution adopted the complete name. Read more Also: Unixstickers Review: Pimp Out Your Laptop

The Money In Open-Source Software

It’s no secret that open-source technology — once the province of radicals, hippies and granola eaters — has gone mainstream. According to industry estimates, more than 180 young companies that give away their software raised roughly $3.2 billion in financing from 2011 to 2014. Even major enterprise-IT vendors are relying on open-source for critical business functions today. It’s a big turnaround from the days when former Microsoft CEO Steve Ballmer famously called the open-source Linux operating system “a cancer” (and obviously a threat to Windows). Read more

Analysis Of The Top 10 Linux Distributions Of 2015

For the past couple of years I have been producing analysis guides for the top 10 Linux distributions as listed on Distrowatch. Click here for the guide for 2013 Click here for the guide for 2014 The point of this article is to look at the top 10 Linux distributions as listed on Distrowatch for the year 2015 and analyse their suitability for the average Joe. The criteria for an Everyday Linux distribution is as follows: Must be relatively easy to install Must have an intuitive desktop environment Must be easy to use Must have a standard set of applications pre-installed (i.e. web browser, audio player, media player) Must have a decent package manager in order to install further software Must be ready to use from the get go The distributions are listed in the order they are in on Distrowatch. Read more

S.F. Officials Push for Adoption of Pioneering Open-Source Voting System

Just over a year ago the Board of Supervisors passed a resolution that required the city to study open-source voting. Last November, the Department of Elections approved a plan asking the mayor and the board to start and fund the work. Arntz said the agency plans to submit a budget request to Mayor Ed Lee at the end of the month, proposing spending $2.3 million toward an open-source system. Read more